Sign in
cache/89f766ad26ef08d3692a413bb90df99f1f1ea1bb4ef4b8e10c78cf32a1f758a4

EURONEXT:MDMA

Pharmala Biotech Holdings Inc.

  • Stock

Last Close

0.11

26/07 13:55

Volume Today

15.54K

Avg: 2.03M

PE Ratio

−61.79

PFCF: −36.83

OverviewFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Aug '21
Aug '22
Aug '23
average inventory
58.17K
-
119.27K
105.03%
average payables
average receivables
55.06K
-
137.02K
148.84%
book value per share
0.03
-
0.02
25.29%
capex per share
-0.00
-
-0.01
294.88%
capex to depreciation
-865.30
-
-81.98
90.53%
-9.60
88.29%
capex to operating cash flow
1.51
-
1.59
5.32%
1.49
6.22%
capex to revenue
-12.74
-
-0.95
92.53%
cash per share
0.03
-
0.01
64.13%
days of inventory on hand
18.56K
-
572.50
96.92%
days payables outstanding
days sales outstanding
236.34
-
153.33
35.12%
debt to assets
0.11
-
debt to equity
0.18
-
dividend yield
earnings yield
-0.38
-
-0.25
34.60%
enterprise value
4.17M
-
3.14M
24.76%
58.49K
98.13%
enterprise value over ebitda
-1.66
-
-3.22
93.91%
-0.08
97.38%
ev to operating cash flow
-24.01
-
-5.01
79.12%
-0.17
96.57%
ev to sales
40.17
-
0.11
99.73%
free cash flow per share
-0.01
-
-0.02
286.93%
free cash flow yield
-0.07
-
-0.41
519.09%
graham net net
0.03
-
0.01
77.06%
graham number
0.15
-
0.08
44.74%
income quality
0.07
-
0.63
817.22%
0.44
31.36%
intangibles to total assets
0.09
-
0.53
473.28%
0.70
32.05%
interest coverage
interest debt per share
inventory turnover
0.02
-
0.64
3,141.91%
invested capital
0.18
-
market cap
6.64M
-
3.99M
39.94%
net current asset value
2.39M
-
661.69K
72.35%
-315.07K
147.62%
net debt to ebitda
0.99
-
0.88
11.17%
-0.08
109.64%
net income per share
-0.03
-
-0.01
59.12%
operating cash flow per share
-0.00
-
-0.01
274.94%
payables turnover
receivables turnover
1.54
-
2.38
54.13%
research and ddevelopement to revenue
-0.31
-
return on tangible assets
-0.99
-
-0.90
8.61%
-1.09
20.36%
revenue per share
0.00
-
roe
-0.94
-
-0.52
45.28%
-0.56
9.02%
roic
-0.94
-
-0.52
45.28%
-0.47
9.94%
sales general and administrative to revenue
13.44
-
2.17
83.89%
shareholders equity per share
0.03
-
0.02
25.29%
stock based compensation to revenue
3.03
-
0.13
95.80%
tangible asset value
2.40M
-
665.49K
72.22%
-312.97K
147.03%
tangible book value per share
0.03
-
0.02
25.29%
working capital
2.39M
-
661.69K
72.35%
-315.07K
147.62%

All numbers in (except ratios and percentages)